Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients
1 other identifier
observational
93
1 country
1
Brief Summary
Among women with HNPCC, this study will assess:
- 1.Knowledge of screening recommendations for endometrial and ovarian cancers.
- 2.Perceived risk and cancer worries regarding endometrial, ovarian and colorectal cancers.
- 3.Adherence to screening recommendations for endometrial, ovarian and colon cancers.
- 4.Perceived benefits,supports and barriers to endometrial and ovarian cancer screening.
- 5.Patterns of communication about endometrial and ovarian cancer risk within families with HNPCC and with health care providers.
- 6.Patient preferences for potential cancer screening and cancer prevention strategies related to HNPCC-associated cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedFirst Submitted
Initial submission to the registry
July 26, 2007
CompletedFirst Posted
Study publicly available on registry
July 30, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedMarch 11, 2016
March 1, 2016
12.8 years
July 26, 2007
March 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Responses to Questionnaire
Outcomes measuring demographics, surveillance behaviors, perceived risk, and cancer worries, screening supports/benefits and barriers.
7 Years
Study Arms (1)
HNPCC Patients
Interventions
Two-part telephone questionnaire lasting about 60 minutes total.
Eligibility Criteria
Women, age 25 years of age or older, diagnosed with Hereditary Non-Polyposis Colon Cancer (HNPCC).
You may qualify if:
- Being female
- Being 25 years of age or older
- Having an HNPCC-predisposing mutation and/or having a family history of cancer that meets the Amsterdam or Amsterdam II criteria for HNPCC
You may not qualify if:
- Persons who have tested negative for a known HNPCC-predisposing mutation in their family
- Persons who have no family HNPCC mutation and have not met the Amsterdam I/II criteria
- Being younger than 25 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Peterson, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2007
First Posted
July 30, 2007
Study Start
May 1, 2003
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
March 11, 2016
Record last verified: 2016-03